Grantham, Mayo, Van Otterloo & Co (GMO)’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-13,800
Closed -$182K 539
2016
Q2
$182K Sell
13,800
-1,400
-9% -$19.9K ﹤0.01% 546
2016
Q1
$232K Sell
15,200
-600
-4% -$9.68K ﹤0.01% 534
2015
Q4
$389K Buy
+15,800
New +$414K ﹤0.01% 457

Other funds holding DK

Grantham, Mayo, Van Otterloo & Co (GMO)'s DK Position: Q3 2016 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Delek US (DK) in Q3 2016, closing a stake of 13,800 shares — an estimated $182K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DK in Q4 2015 and held it in 3 quarters. The position peaked at $389K in Q4 2015. 150 funds tracked by Wall St. Rank hold DK as of Q3 2016.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Delek US position as of Q3 2016 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 13,800 Delek US shares in Q3 2016, an estimated $182K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Delek US in Q4 2015 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Delek US position peaked at $389K in Q4 2015.
  • 150 funds tracked by Wall St. Rank held Delek US as of Q3 2016.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2016, filed 10 Nov 2016.